Veradigm (NASDAQ:MDRX) Shares Down 10.7% – Should You Sell?

Veradigm Inc. (NASDAQ:MDRXGet Free Report) shares traded down 10.7% during trading on Monday . The company traded as low as $4.55 and last traded at $4.55. 1,269 shares changed hands during trading, a decline of 99% from the average daily volume of 153,126 shares. The stock had previously closed at $5.0950.

Veradigm Price Performance

The company has a market cap of $580.92 million, a P/E ratio of 23.25 and a beta of 0.53. The stock has a fifty day moving average price of $4.86 and a two-hundred day moving average price of $4.67.

About Veradigm

(Get Free Report)

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

Read More

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.